These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 6572760)
21. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456 [TBL] [Abstract][Full Text] [Related]
22. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. McArthur GA; Longmore GD; Klingler K; Johnson GR Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257 [TBL] [Abstract][Full Text] [Related]
23. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
24. Comparative effects of polycythemia-inducing Friend leukemia virus and Moloney leukemia virus on hematopoietic progenitors in murine long-term bone marrow cultures. Heard JM; Fichelson S; Gisselbrecht S; Varet B Cancer Res; 1981 Aug; 41(8):3260-5. PubMed ID: 6972804 [TBL] [Abstract][Full Text] [Related]
25. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related]
26. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658 [TBL] [Abstract][Full Text] [Related]
27. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340 [TBL] [Abstract][Full Text] [Related]
28. Morphological changes in erythroblasts during erythropoietin-induced terminal differentiation in vitro. Koury ST; Koury MJ; Bondurant MC Exp Hematol; 1988 Oct; 16(9):758-63. PubMed ID: 3169158 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin responsiveness in vivo of Friend virus target cells for transformation and virus replication. Nasrallah AG; McGarry MP Cancer Res; 1978 Nov; 38(11 Pt 1):3774-8. PubMed ID: 698937 [TBL] [Abstract][Full Text] [Related]
30. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation. Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110 [TBL] [Abstract][Full Text] [Related]
31. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. Ashihara E; Vannucchi AM; Migliaccio G; Migliaccio AR J Cell Physiol; 1997 Jun; 171(3):343-56. PubMed ID: 9180904 [TBL] [Abstract][Full Text] [Related]
32. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Wood PA; Hrushesky WJ; Klevecz R Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286 [TBL] [Abstract][Full Text] [Related]
33. [Morphological observation of erythroid progenitor cell differentiation in vitro]. Zhang QY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):210-4. PubMed ID: 2529990 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of the growth of human early erythroid progenitors by bone marrow conditioned media. Porter PN; Ogawa M; Leary AG Exp Hematol; 1980 Jan; 8(1):83-8. PubMed ID: 7409039 [TBL] [Abstract][Full Text] [Related]
35. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow. Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025 [TBL] [Abstract][Full Text] [Related]
36. Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Kelley LL; Green WF; Hicks GG; Bondurant MC; Koury MJ; Ruley HE Mol Cell Biol; 1994 Jun; 14(6):4183-92. PubMed ID: 8196656 [TBL] [Abstract][Full Text] [Related]
37. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice. Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998 [TBL] [Abstract][Full Text] [Related]
38. Erythroid colony production in vitro as a function of exposure time to erythropoietin. Kennedy WL; Alpen EL; Garcia JF Blood Cells; 1978; 4(1-2):143-54. PubMed ID: 747768 [TBL] [Abstract][Full Text] [Related]
39. Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice. Chang MJ; Pourbohloul SC; Yu WD; Furmanski P; Johnson CS Exp Hematol; 1992 Dec; 20(11):1271-7. PubMed ID: 1337323 [TBL] [Abstract][Full Text] [Related]
40. Induction of globin mRNA transcription by erythropoietin in differentiating erythroid precursor cells. Nijhof W; Wierenga PK; Sahr K; Beru N; Goldwasser E Exp Hematol; 1987 Aug; 15(7):779-84. PubMed ID: 3609181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]